About CSA Products Support & Training News and Events Contact Us
Discovery Guides Areas


STD Protection With or Without Contraception

(Released January 2002)

  by Robert Lessick  


Key Citations

Web Sites



Key Citations Short Format Full Format
Choose a Category New Microbicides Policy Clinical Trials Vaginal Microflora
  Attitudes & Behavior Nonoxynol-9
  1. Protegrin structure and activity against Neisseria gonorrhoeae
    Infection and Immunity [Infect. Immun.], vol. 65, no. 2, pp. 636-639, Feb 1997

  2. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: Potential applications to microbicide development
    Antimicrobial Agents & Chemotherapy [Antimicrob. Agents Chemother.], vol. 41, no. 7, pp. 1521-1530, Jul 1997

  3. Effect of undecylenic acid as a topical microbicide against genital herpes infection in mice and guinea pigs
    Antiviral Research [Antiviral Res.], vol. 40, no. 3, pp. 139-144, 1 Jan 1999

  4. Bile salts: Natural detergents for the prevention of sexually transmitted diseases
    Antimicrobial Agents & Chemotherapy [Antimicrob. Agents Chemother.], vol. 43, no. 4, pp. 745-751, Apr 1999

  5. Plant products as topical microbicide candidates: assessment of in vitro and in vivo activity against herpes simplex virus type 2
    Antiviral Research [Antiviral Res.], vol. 42, no. 3, pp. 219-226, 1 Jul 1999

  6. Hydrogels Containing Monocaprin Prevent Intravaginal and Intracutaneous Infections With HSV-2 in Mice: Impact on the Search for Vaginal Microbicides
    Journal of Medical Virology [J. Med. Virol.], vol. 61, no. 1, pp. 107-110, May 2000

  7. Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection
    Antimicrobial Agents & Chemotherapy [Antimicrob. Agents Chemother.], vol. 44, no. 9, pp. 2471-2474, Sep 2000

  8. Transgenic commensals as mucosal protectants
    Nature Biotechnology [Nat. Biotechnol.], vol. 18, no. 10, pp. 1038-1039, Oct 2000

  9. In vitro inactivation of Chlamydia trachomatis and of a panel of DNA (HSV-2, CMV, adenovirus, BK virus) and RNA (RSV, enterovirus) viruses by the spermicide benzalkonium chloride
    Journal of Antimicrobial Chemotherapy [J. Antimicrob. Chemother.], vol. 46, no. 5, pp. 685-693, Nov 2000

  10. Candidate Microbicides Block HIV-1 Infection of Human Immature Langerhans Cells within Epithelial Tissue Explants
    Journal of Experimental Medicine [J. Exp. Med.], vol. 192, no. 10, pp. 1491-1500, 20 Nov 2000

  11. Thermoreversible gel as a candidate barrier to prevent the transmission of HIV-1 and herpes simplex virus type 2.
    Sexually transmitted diseases., 2001 Aug, 28(8):484-91

  12. Preclinical evaluation of docusate as protective agent from herpes simplex viruses
    Antiviral Research [Antiviral Res.], vol. 52, no. 1, pp. 25 - 32, 1 Oct 2001

  13. In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses
    Journal of Clinical Microbiology [J. Clin. Microbiol.], vol. 38, no. 1, pp. 110-119, Jan 2000

  14. Sodium lauryl sulfate abrogates human immunodeficiency virus infectivity by affecting viral attachment
    Antimicrobial Agents & Chemotherapy [Antimicrob. Agents Chemother.], vol. 45, no. 8, pp. 2229-2237, Aug 2001

  15. A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses
    Antimicrobial Agents & Chemotherapy [Antimicrob. Agents Chemother.], vol. 43, no. 2, pp. 314-321, Feb 1999

  16. Design of a "Microbicide" for Prevention of Sexually Transmitted Diseases Using "Inactive" Pharmaceutical Excipients
    Biologicals, vol. 27, no. 1, pp. 11-21, Mar 1999

  17. Effect of a cellulose acetate phthalate topical cream on vaginal transmission of simian immunodeficiency virus in rhesus monkeys
    Antimicrobial Agents & Chemotherapy [Antimicrob. Agents Chemother.], vol. 44, no. 11, pp. 3199-3202, Nov 2000

  18. Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide.
    Sex Transm Infect, 2000 Dec, 76(6):480-3

  19. Tests of Buffergel for contraception and prevention of sexually transmitted diseases in animal models.
    Sexually transmitted diseases., 2001 Jul, 28(7):417-23

  20. Phase 1 Trial of the Topical Microbicide BufferGel: Safety Results From Four International Sites
    JAIDS Journal of Acquired Immune Deficiency Syndromes [Jaids J. Acquired Immune Defic. Syndromes], vol. 26, no. 1, pp. 21-27, Jan 2001

  21. Safety and Tolerability of BufferGel, a Novel Vaginal Microbicide, in Women in the United States
    Clinical Infectious Diseases [Clin. Infect. Dis.], vol. 32, no. 3, pp. 476-482, 1 Feb 2001